Friday, September 25, 2026

Recurrent Pregnancy Loss

Recurrent Pregnancy Loss — Evaluation & Management
Swaraj Hospital logo
SWARAJ HOSPITAL & RESEARCH INSTITUTE
BOLANGIR, ODISHA  •  OBSTETRICS & GYNAECOLOGY CLINICAL PATHWAY SERIES
Clinician Reference Infographic

Recurrent Pregnancy Loss — Evaluation & Management

Recurrent pregnancy loss (RPL) is generally defined as two or more consecutive pregnancy losses before 20–24 weeks — some societies still use a threshold of three, and definitions vary, so check which convention your workup pathway follows. Behind the definition sits a couple who deserve a thorough, unhurried evaluation — and the honest reassurance that even without a clear cause, most go on to have a successful pregnancy.

Causes broadly fall into four categories: genetic, anatomic, endocrine, and autoimmune — with a substantial share remaining unexplained even after full evaluation

GREEN — One early loss: common and usually not an indication for formal workup; offer reassurance
AMBER — Two consecutive losses: consider starting evaluation, individualized by age, anxiety, and reproductive history
RED — Three or more losses, or any second-trimester loss: full RPL workup is indicated
Timing is a clue: first-trimester losses point more toward genetic/chromosomal causes; a second-trimester loss shifts suspicion toward an anatomic cause or cervical insufficiency.
ЁЯзм THE FOUR CATEGORIES OF CAUSE

Genetic: a parental balanced translocation (2–4% of couples), or sporadic embryonic aneuploidy — the single most common cause of any individual loss, rising with maternal age

Anatomic: a septate uterus (the anomaly most strongly linked to RPL), intrauterine adhesions, submucosal fibroids, or cervical insufficiency (second-trimester pattern)

Endocrine: poorly controlled diabetes, untreated thyroid dysfunction, hyperprolactinaemia

Autoimmune: antiphospholipid syndrome (APS) — the best-established and most treatable cause in this category

1
Parental karyotyping — both partners, looking for a balanced translocation
2
Karyotype of products of conception, where available, especially after a second or third loss
3
Pelvic imaging — 3D ultrasound, saline infusion sonography, or MRI to assess uterine anatomy
4
Antiphospholipid antibodies — lupus anticoagulant, anticardiolipin, and anti-╬▓2-glycoprotein I, each confirmed twice, 12 weeks apart
5
Thyroid function (TSH) and glycaemic screening where risk factors are present
Routine testing for most inherited thrombophilias (beyond APS) is increasingly not recommended by major guidelines — the evidence linking them causally to RPL is weak.
⚕️ ANTIPHOSPHOLIPID SYNDROME — DON'T MISS THIS ONE

Diagnosed with a clinical criterion (pregnancy loss or thrombosis) plus a laboratory criterion (persistent antibody positivity on two occasions, 12 weeks apart)

Of all RPL causes, this is the one where treatment most clearly and consistently improves the live birth rate

Management: low-dose aspirin plus prophylactic heparin/LMWH in a future pregnancy — started as soon as pregnancy is confirmed, per protocol.
Genetic (Parental Translocation)

Genetic counselling is essential

Options include PGT-SR with IVF, or natural conception with prenatal diagnosis (CVS/amniocentesis)

Anatomic

Hysteroscopic septum resection improves outcomes in a septate uterus

Cervical insufficiency is managed with cerclage in a future pregnancy

Endocrine

Optimize thyroid function before conception

Optimize glycaemic control if diabetic

Unexplained

Supportive, closely-monitored early pregnancy care

Aspirin and progesterone are sometimes used, though evidence is mixed — individualize

For Counselling

Most Go On To Have a Baby

60–75%
LIVE BIRTH RATE
NEXT PREGNANCY
Even after multiple unexplained losses, most women who conceive again will carry a pregnancy to a live birth with supportive care alone. The number of prior losses and maternal age matter more for prognosis than whether a specific cause was ever found.

A full workup finds no clear cause in up to half of couples — this is common, not a failure of testing

Supportive, closely-monitored care in early pregnancy ("tender loving care") is itself linked to better outcomes in trials

Grief and anxiety after repeated loss are normal — pair medical reassurance with genuine emotional support, not just a test result

Reminder: "unexplained" is a description of our testing, not a verdict on the pregnancy ahead.

No comments:

About Me